Henley Cheung

Appearances

RNA N<sup>6</sup>-METHYLADENOSINE READER YTHDF1 PROMOTES STEMNESS AND DRUG RESISTANCE OF COLORECTAL CANCER THROUGH INDUCING NOTCH1 AND IS A THERAPEUTIC TARGET
Date
May 6, 2023
BACKGROUND: Immune checkpoint blockade has revolutionized cancer treatment by harnessing the patient’s native anti-tumor T cells, but most colorectal cancers do not respond, for unclear reasons…
Presenter
Henley Cheung
Speakers
Huarong Chen
Chi Chun Wong
Heming Zhou
Weixin Liu
Jun Yu
RNA N6-METHYLADENOSINE ERASER ALKBH5 DRIVES STEMNESS AND CHEMORESISTANCE OF COLORECTAL CANCER THROUGH A M6A-FAM84A-Β-CATENIN AXIS
Date
May 20, 2024
BACKGROUND: RNA N6-methyladenoine (m6A) modification plays multifaceted roles in cancer, including tumor initiation, progression and therapy resistance. Nevertheless, the role of aberrant m6A in cancer stem cells (CSCs) remains unclear…
Presenter
Heming Zhou
Speakers
Chi Chun Wong
Huarong Chen
Henley Cheung
Weixin Liu
Cong Liang
Jun Yu